State of Alaska Department of Revenue’s Cytek Biosciences CTKB Stock Holding History

State of Alaska Department of Revenue’s Portfolio CTKB Stock Details CTKB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$28K	Sell	6,456 -54,813	-89%	-$234K	﹤0.01%	2026
2026 Q1	$267K	Hold	61,269	–	–	﹤0.01%	1593
2025 Q4	$308K	Sell	61,269 -240	-0.4%	-$1.11K	﹤0.01%	1582
2025 Q3	$213K	Buy	61,509 +556	+0.9%	+$2.09K	﹤0.01%	1579
2025 Q2	$206K	Buy	60,953 +3,141	+5%	+$10.5K	﹤0.01%	1553
2025 Q1	$231K	Sell	57,812 -1,485	-3%	-$7.7K	﹤0.01%	1545
2024 Q4	$384K	Sell	59,297 -1,488	-2%	-$8.86K	﹤0.01%	1469
2024 Q3	$336K	Buy	60,785 +4,521	+8%	+$25.6K	﹤0.01%	1521
2024 Q2	$313K	Sell	56,264 -4,016	-7%	-$24.1K	﹤0.01%	1519
2024 Q1	$404K	Sell	60,280 -594	-1%	-$4.7K	﹤0.01%	1451
2023 Q4	$555K	Sell	60,874 -1,095	-2%	-$6.89K	0.01%	1306
2023 Q3	$342K	Buy	61,969 +9,302	+18%	+$74.6K	﹤0.01%	1489
2023 Q2	$449K	Buy	+52,667	New	+$472K	0.01%	1420

Other funds holding CTKB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

State of Alaska Department of Revenue's CTKB Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its Cytek Biosciences (CTKB) stake by 89% in Q2 2026, selling an estimated $234K and leaving 6,456 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #2026.

State of Alaska Department of Revenue first reported a position in CTKB in Q2 2023 and has held it in 13 quarters since. The position peaked at $555K in Q4 2023. 75 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

State of Alaska Department of Revenue held 6,456 shares of Cytek Biosciences worth $28K as of Q2 2026.
State of Alaska Department of Revenue sold 54,813 Cytek Biosciences shares in Q2 2026, an estimated $234K.
Cytek Biosciences made up ﹤0.01% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #2026 holding.
State of Alaska Department of Revenue first reported a position in Cytek Biosciences in Q2 2023 and has held it in 13 quarters since.
State of Alaska Department of Revenue's Cytek Biosciences position peaked at $555K in Q4 2023.
75 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.